---
title: "AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293502785.md"
description: "Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-22T17:03:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293502785.md)
  - [en](https://longbridge.com/en/news/293502785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293502785.md)
---

# AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress

Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged.

Based on

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AXTA.US](https://longbridge.com/en/quote/AXTA.US.md)

## Related News & Research

- [AXTA: Record Q2 results with margin gains, robust cash flow, and progress on the AkzoNobel merger](https://longbridge.com/en/news/294050377.md)
- [Akzo Nobel Q2 2026 Results Show Margin Gains Amid Revenue Pressure and Axalta Merger Plans](https://longbridge.com/en/news/293502616.md)
- [XIFR: Q2 2026 delivered robust financials and strategic progress, supporting long-term value creation](https://longbridge.com/en/news/294079709.md)
- [OSK: Q2 2026 sales rose 6.7% but margins declined; 2026 EPS guidance was revised lower](https://longbridge.com/en/news/294100394.md)
- [Axalta Q2 sales and adjusted EPS beat estimates on acquisitions](https://longbridge.com/en/news/294046791.md)